Brief: Standard Biotools Upon Termination Of Deal, Co May Be Required To Pay Somalogic Fee Of $19.1 Million And/Or Reimburse Somalogic's Expenses Up To $2 Million
04/10/2023 13:51
Oct 4 (Reuters) - Standard BioTools Inc LAB.O :
* STANDARD BIOTOOLS: UPON TERMINATION OF DEAL, CO MAY BE
REQUIRED
TO PAY SOMALOGIC FEE OF $19.1 MILLION AND/OR REIMBURSE
SOMALOGIC'S EXPENSES UP TO $2 MILLION
* STANDARD BIOTOOLS: UPON TERMINATION OF DEAL BY SOMALOGIC,
SOMALOGIC MAY REQUIRED TO PAY CO FEE OF $17.2 MILLION AND/OR
REIMBURSE EXPENSES UP TO OF $2 MILLION
Source text for Eikon: ID:
Further company coverage: LAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders